China A and H-share performance

China Valuations Looking More Reasonable: Macquarie

Following the recent 20% stock market correction, valuations in China look a good deal more reasonable, although current multiples for Staples, Healthcare and IT still look stretched, notes Macquarie.

Joshua van Lin of Macquarie Capital Securities in the Asia strategy research report titled: “China: Taking stock”, notes ROE erosion in big SOE sectors is a drag on MSCI China.
Most China stocks now at reasonable valuations
Drawing attention to Macquarie’s April 30, 2015 report titled: “Are H-shares overvalued?”, the analyst recalls the . . .

SORRY!

This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here

If you are subscribed and having an account error please clear cache and then cookies if that does not work email support@valuewalk.com and we will get back to you as quick as humanly possible


Saved Articles
X
TextTExtLInkTextTExtLInk

Are you a smart investor? Join tens of thousands of sophisticated investor reading our authoritative free newsletter

* indicates required


Congrats! Are you a smart person?

We have an exclusive targeted for being a sophisticated and loyal reader.

Sign up today and get three months free

Use coupon code vip19 or click on the button below

Limited time offer only ENDS 10/31/2019 or after next 25 20 subscribers take advantage whichever comes first – please do not share this discount with others

 

0